Business Description
Janux Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US47103J1051
Share Class Description:
JANX: Ordinary SharesDescription
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 26.95 | |||||
Equity-to-Asset | 0.95 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.34 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 41.97 | |||||
Beneish M-Score | 3.01 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -45.3 | |||||
3-Year EPS without NRI Growth Rate | -34.4 | |||||
3-Year FCF Growth Rate | -50.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | -14.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.32 | |||||
9-Day RSI | 59.93 | |||||
14-Day RSI | 53.83 | |||||
6-1 Month Momentum % | 313.79 | |||||
12-1 Month Momentum % | 237.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 62.09 | |||||
Quick Ratio | 62.09 | |||||
Cash Ratio | 61.43 | |||||
Days Sales Outstanding | 31.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5 | |||||
Shareholder Yield % | -13.97 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -999.85 | |||||
Net Margin % | -762.92 | |||||
FCF Margin % | -730.93 | |||||
ROE % | -14.18 | |||||
ROA % | -12.92 | |||||
ROIC % | -190.78 | |||||
ROC (Joel Greenblatt) % | -257.59 | |||||
ROCE % | -17.53 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 286.1 | |||||
PB Ratio | 3.6 | |||||
Price-to-Tangible-Book | 3.6 | |||||
EV-to-EBIT | -22.63 | |||||
EV-to-EBITDA | -23.28 | |||||
EV-to-Revenue | 226.25 | |||||
EV-to-Forward-Revenue | 483.33 | |||||
EV-to-FCF | -31.32 | |||||
Price-to-Net-Current-Asset-Value | 3.77 | |||||
Price-to-Net-Cash | 3.81 | |||||
Earnings Yield (Greenblatt) % | -4.42 | |||||
FCF Yield % | -2.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:JANX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Janux Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 7.287 | ||
EPS (TTM) ($) | -1.21 | ||
Beta | 3.55 | ||
Volatility % | 475.24 | ||
14-Day RSI | 53.83 | ||
14-Day ATR ($) | 2.445809 | ||
20-Day SMA ($) | 40.9675 | ||
12-1 Month Momentum % | 237.08 | ||
52-Week Range ($) | 5.65 - 65.6 | ||
Shares Outstanding (Mil) | 51.85 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Janux Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Janux Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Janux Therapeutics Inc Frequently Asked Questions
What is Janux Therapeutics Inc(JANX)'s stock price today?
The current price of JANX is $45.50. The 52 week high of JANX is $65.60 and 52 week low is $5.65.
When is next earnings date of Janux Therapeutics Inc(JANX)?
The next earnings date of Janux Therapeutics Inc(JANX) is 2024-08-08 Est..
Does Janux Therapeutics Inc(JANX) pay dividends? If so, how much?
Janux Therapeutics Inc(JANX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |